According to the SEC filing, Benzeno sold a total of 44,665 shares on March 5, 2025, at prices ranging from $6.98 to $6.99 per share. The total value …
Adaptive Biotechnologies' chief commercial officer Sharon Benzeno sells $311,792 in stock …
ByDaniel Wege
mar 8, 2025
By Daniel Wege
Consultor HAZOP Especializado em IA | 20+ Anos Transformando Riscos em Resultados | Experiência Global: PETROBRAS, SAIPEM e WALMART